news
20 November 2019
Genpharm Initiates Gene Therapy for SMA Patients in Kuwait & Qatar
Share
Genpharm is very proud to support access to gene therapy treatments for patients in the Middle East.
After years of extensive research, Gene therapy offers now great hope for rare disease patients.
Click here to learn about the initiation of Gene therapy in Kuwait, and here for the initiation in Qatar, the first countries in the world after the USA to treat SMA patients.